Comparative study of seven commercial yeast identification systems

Area of Science:

• Medical Mycology
• Clinical Microbiology
• Diagnostic Accuracy

Background:

• Accurate yeast identification is crucial for effective clinical treatment.
• Commercial identification systems offer potential efficiency gains over conventional methods.

Purpose of the Study:

• To evaluate the diagnostic performance and cost-effectiveness of seven commercial yeast identification kits.
• To compare these kits against a standard reference method using clinical isolates.

Main Methods:

• Fifty-two clinical yeast isolates, representing 19 species, were tested.
• Methods included Vitek, Api ID 32C, Api 20C AUX, Yeast Star, Auxacolor, RapID Yeast Plus, and Api Candida.
• Comparison was made against a reference method utilizing conventional microbiological tests.

Main Results:

• Overall correct identification rates ranged from 59.6% to 80.8%.
• Api Candida (78.8%) and Auxacolor (80.8%) showed the highest performance.
• For germ tube-negative yeasts, Auxacolor and Api Candida achieved 93.1% accuracy.
• C. norvegensis, C. catenulata, C. haemulonii, and C. dubliniensis were not identified by any system.
• Api Candida was found to be more cost-effective and time-efficient than Auxacolor.

Conclusions:

• Auxacolor and Api Candida are recommended for identifying germ tube-negative yeasts in clinical labs.
• Laboratories should be aware of the limitations regarding the identification of specific Candida species.
• Further development is needed to improve the identification capabilities for all clinically relevant yeast species.